InnoUp Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Later Stage VC
- Investors
-
9
InnoUp General Information
Description
Developer of a patented nanotechnology drug delivery platform designed to improve the efficacy and safety of drugs. The company offers an encapsulation platform based on biocompatible nanoparticles with bioadhesive capacity, which is selective and effective and therefore offers less toxic drugs, enabling patients access to safe medications at affordable rates.
Contact Information
Website
www.innoupfarma.comCorporate Office
- Carretera de Pamplona, 1
- Edificio, Cordovilla
- 31191 AIN
- Spain
Corporate Office
- Carretera de Pamplona, 1
- Edificio, Cordovilla
- 31191 AIN
- Spain
InnoUp Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | 01-Jan-2024 | Completed | Clinical Trials - Phase 2 | |||
| 6. Later Stage VC (Series 2) | 28-Dec-2020 | Completed | Clinical Trials - Phase 2 | |||
| 5. Grant | 10-Sep-2020 | Completed | Clinical Trials - Phase 2 | |||
| 4. Equity Crowdfunding | 24-Apr-2020 | Completed | Clinical Trials - Phase 2 | |||
| 3. Later Stage VC | 09-May-2019 | Completed | Clinical Trials - Phase 2 | |||
| 2. Seed Round | 08-Nov-2015 | $2.23M | $2.23M | Completed | Clinical Trials - Phase 2 | |
| 1. Accelerator/Incubator | 21-Jan-2015 | Completed | Startup |
InnoUp Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Ordinary | ||||||||
| Series A | 30,812 | $1.213766 | $42.15 | $42.15 | 1x | $42.15 | 22.42% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
InnoUp Patents
InnoUp Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026167127-A1 | Zein nanoparticles for use in the treatment of allergies and as immunoadjuvants | Pending | 05-Feb-2025 | ||
| AU-2022315544-A1 | Mixing device | Pending | 22-Jul-2021 | ||
| CA-3226453-A1 | Mixing device | Pending | 22-Jul-2021 | ||
| EP-4373605-A1 | Mixing device | Active | 22-Jul-2021 | ||
| EP-4373605-B1 | Mixing device | Active | 22-Jul-2021 | B01J2/04 |
InnoUp Signals
InnoUp Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Medex Partners | Venture Capital | Minority | ||
| INNVIERTE SICC | Government | Minority | ||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| WA4STEAM | Angel Group | Minority |
InnoUp FAQs
-
When was InnoUp founded?
InnoUp was founded in 2013.
-
Where is InnoUp headquartered?
InnoUp is headquartered in AIN, Spain.
-
What is the size of InnoUp?
InnoUp has 8 total employees.
-
What industry is InnoUp in?
InnoUp’s primary industry is Drug Delivery.
-
Is InnoUp a private or public company?
InnoUp is a Private company.
-
What is InnoUp’s current revenue?
The current revenue for InnoUp is .
-
How much funding has InnoUp raised over time?
InnoUp has raised $6.18M.
-
Who are InnoUp’s investors?
Medex Partners, INNVIERTE SICC, , , and WA4STEAM are 5 of 9 investors who have invested in InnoUp.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process